Trials / Completed
CompletedNCT00161798
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
Double-blind, Randomized, Multicenter Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 6 Years – 15 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the safety and immunogenicity of three different concentrations of a TBE vaccine will be investigated in healthy children aged 6 to 16 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tick-borne encephalitis vaccine |
Timeline
- Start date
- 2001-09-01
- Completion
- 2002-03-01
- First posted
- 2005-09-13
- Last updated
- 2015-05-21
Locations
23 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00161798. Inclusion in this directory is not an endorsement.